Physician profile
Benjamin S Schmidt
NPI 1093032328
$572.46
in general payments reported to CMS, 2019-2025
18 companies · $89.87 in 2025
The $89.87 reported for 2025 was less than what a typical General Practice provider received nationally (typical 2025 total: $105).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.15 · 2020: $90.09 · 2021: $171 · 2022: $88.99 · 2023: $34.61 · 2024: $19.91 · 2025: $89.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $144.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $121.38 | 2020-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $63.50 | 2020-2022 | |
| Pfizer INC. | $59.11 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.65 | 2021 | |
| Conmed Corporation | $36.11 | 2019 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $30.64 | 2022 | |
| Janssen Pharmaceuticals, INC | $26.52 | 2020 | |
| Novartis Pharmaceuticals Corporation | $25.67 | 2019 | |
| Pulmonx Corporation | $23.39 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.06 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $18.96 | 2021 | |
| Sanofi-Aventis U.S. LLC | $17.87 | 2020 | |
| Sanofi Pasteur INC. | $16.37 | 2019 | |
| Baxter Healthcare | $16.35 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Amarin Pharma, INC. | $14.94 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.29 | 2022 | |
| Abbvie INC. | $13.86 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Schmidt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.